-
1دورية أكاديمية
المؤلفون: Naidoo, Jarushka, Vansteenkiste, Johan F., Faivre-Finn, Corinne, Ozguroglu, Mustafa, Murakami, Shuji, Hui, Rina, Antonia, Scott J.
مصطلحات موضوعية: Locally advanced NSCLC, Pneumonitis, Immune checkpoint inhibition, Thyroid disorders, Chemoradiotherapy, PACIFIC, Docetaxel, Nivolumab, Pembrolizumab, Chemotherapy, Inhibitor, Anti-Pd-1
العلاقة: Lung Cancer; Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı; https://doi.org/10.1016/j.lungcan.2022.02.003Test; https://hdl.handle.net/20.500.12831/7781Test; 166; 84; 93; WOS:000791997800011; 2-s2.0-85125438748
الإتاحة: https://doi.org/10.1016/j.lungcan.2022.02.003Test
https://doi.org/20.500.12831/7781Test
https://hdl.handle.net/20.500.12831/7781Test -
2دورية أكاديمية
المؤلفون: Naidoo, Jarushka, Wang, Xuan, Woo, Kaitlin M., Iyriboz, Tunc, Halpenny, Darragh, Cunningham, Jane, Chaft, Jamie E., Segal, Neil H., Callahan, Margaret K., Lesokhin, Alexander M., Rosenberg, Jonathan, Voss, Martin H., Rudin, Charles M., Rizvi, Hira, Hou, Xue, Rodriguez, Katherine, Albano, Melanie, Gordon, Ruth-Ann, Leduc, Charles, Rekhtman, Natasha, Harris, Bianca, Menzies, Alexander M., Guminski, Alexander D., Carlino, Matteo S., Kong, Benjamin Y., Wolchok, Jedd D., Postow, Michael A., Long, Georgina V., Hellmann, Matthew D.
المساهمون: Hellmann, MD (reprint author), Mem Sloan Kettering Canc Ctr, 300 E 66th St, New York, NY 10065 USA., Mem Sloan Kettering Canc Ctr, 300 E 66th St, New York, NY 10065 USA., Weill Cornell Med Coll, New York, NY USA., Johns Hopkins Univ, Sidney Kimmel Canc Ctr, Baltimore, MD USA., Peking Univ Canc Hosp & Inst, Beijing, Peoples R China., Sun Yat Sen Univ, Ctr Canc, Guangzhou, Guangdong, Peoples R China., Univ Sydney, Sydney, NSW, Australia., Royal North Shore & Mater Hosp, Melbourne, Vic, Australia., Westmead Hosp, Sydney, NSW, Australia., Blacktown Hosp, Sydney, NSW, Australia.
المصدر: SCI ; PubMed
مصطلحات موضوعية: CELL LUNG-CANCER, INTERSTITIAL PNEUMONITIS, PULMONARY TOXICITY, ADVANCED MELANOMA, PD-1 BLOCKADE, NIVOLUMAB, DOCETAXEL, ANTI-PD-1, IMMUNOTHERAPY, PEMBROLIZUMAB
العلاقة: JOURNAL OF CLINICAL ONCOLOGY.2017,35(7),709-+.; 1437739; http://hdl.handle.net/20.500.11897/492713Test; WOS:000396366100004
الإتاحة: https://doi.org/20.500.11897/492713Test
https://doi.org/10.1200/JCO.2016.68.2005Test
https://hdl.handle.net/20.500.11897/492713Test -
3دورية أكاديمية
المؤلفون: Marrone, Kristen A.1, Naidoo, Jarushka1 jnaidoo1@jhmi.edu, Brahmer, Julie R.1
المصدر: Seminars in Respiratory & Critical Care Medicine. 2016, Vol. 37 Issue 5, p771-782. 12p.
مصطلحات موضوعية: *LUNG cancer treatment, *LUNG cancer patients, *IMMUNOTHERAPY, *ANTINEOPLASTIC agents, *IMMUNOSUPPRESSION, *THERAPEUTIC use of monoclonal antibodies, *TREATMENT of lung tumors
-
4دورية أكاديمية
المؤلفون: Wills, Beatriz, Brahmer, Julie R., Naidoo, Jarushka
المصدر: Current Treatment Options in Oncology; Sep2018, Vol. 19 Issue 9, p1-1, 1p